The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22090
StudyName: Eligibility Non-Hodgkin's Lymphoma NCT00336583
Date of export from the portal: 02.07.2020
Date of Upload / last change: 19.05.2017
License: Creative Commons BY 4.0

----

Description: 
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00336583
